Corrigendum to 'Anti-ICOS Monoclonal Antibody Treatment of Canine Chronic GVHD' [Biology of Blood and Marrow Transplantation 24/1 (2018) 50-54].

Autor: Graves SS; Transplantation Biology Program, Fred Hutchinson Cancer Research Center, Seattle, Washington., Parker MH; Transplantation Biology Program, Fred Hutchinson Cancer Research Center, Seattle, Washington., Stone D; Transplantation Biology Program, Fred Hutchinson Cancer Research Center, Seattle, Washington., Sale GE; Transplantation Biology Program, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Pathology, University of Washington School of Medicine, Seattle, Washington., Pillai SPS; Transplantation Biology Program, Fred Hutchinson Cancer Research Center, Seattle, Washington., Johnson MM; Transplantation Biology Program, Fred Hutchinson Cancer Research Center, Seattle, Washington., Storb R; Transplantation Biology Program, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, Division of Oncology, University of Washington, Seattle, Washington. Electronic address: rstorb@fredhutch.org.
Jazyk: angličtina
Zdroj: Transplantation and cellular therapy [Transplant Cell Ther] 2022 Oct; Vol. 28 (10), pp. 718-719. Date of Electronic Publication: 2020 Sep 03.
DOI: 10.1016/j.bbmt.2020.08.023
Databáze: MEDLINE
Externí odkaz: